Rafael Holdings, Inc. Class B Common Stock (RFL)
2.0600
+0.1000 (5.10%)
Rafael Holdings Inc is a clinical-stage investment company that focuses on developing novel cancer therapies and related technologies
The company primarily invests in and supports early-stage biotech and pharmaceutical ventures, particularly those that are working on innovative treatment solutions targeting various types of cancer. In addition to its investments, Rafael Holdings is also engaged in the research and development of its own proprietary drug candidates, aiming to contribute to advancements in cancer treatment and improve patient outcomes through cutting-edge therapeutic approaches.
Frequently Asked Questions
Is Rafael Holdings, Inc. Class B Common Stock publicly traded?
Yes, Rafael Holdings, Inc. Class B Common Stock is publicly traded.
What exchange does Rafael Holdings, Inc. Class B Common Stock trade on?
Rafael Holdings, Inc. Class B Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Rafael Holdings, Inc. Class B Common Stock?
The ticker symbol for Rafael Holdings, Inc. Class B Common Stock is RFL on the New York Stock Exchange
What is the current price of Rafael Holdings, Inc. Class B Common Stock?
The current price of Rafael Holdings, Inc. Class B Common Stock is 2.060
When was Rafael Holdings, Inc. Class B Common Stock last traded?
The last trade of Rafael Holdings, Inc. Class B Common Stock was at 7:00 pm EST on January 31st, 2025
What is the market capitalization of Rafael Holdings, Inc. Class B Common Stock?
The market capitalization of Rafael Holdings, Inc. Class B Common Stock is 206.00
How many shares of Rafael Holdings, Inc. Class B Common Stock are outstanding?
Rafael Holdings, Inc. Class B Common Stock has 100.00 shares outstanding.